Target intelligence / Profile preview

Cellular Nucleic Acids (DNA and RNA) (DNA/RNA)

Target
DNA/RNA
Molecular classification
Other
01

Overview

Cellular DNA and RNA, collectively known as nucleic acids, serve as the fundamental blueprints and functional templates for life. DNA stores the hereditary information required for the development and functioning of all living organisms, while RNA plays critical roles in translating that information into proteins and regulating gene expression (Source: NIH). In the context of pharmacology, these molecules are primary targets for a wide range of therapeutic agents. Traditional chemotherapies often target DNA through alkylation or intercalation to induce cell death in rapidly dividing cancer cells, particularly in oncology (Source: PubMed). Modern therapeutics, such as antisense oligonucleotides and siRNA, target specific RNA sequences to modulate protein production for treating genetic and rare diseases (Source: Nature Reviews Drug Discovery). Despite their therapeutic utility, targeting nucleic acids poses significant safety challenges, including the risk of off-target genetic damage and secondary malignancies due to their ubiquitous presence and essential nature.

Other names
Deoxyribonucleic acidRibonucleic acidGenetic materialPolynucleotides
02

Mechanism of action

Drugs targeting nucleic acids act through various mechanisms including DNA alkylation (cross-linking strands), intercalation (inserting between base pairs), inhibition of topoisomerases, antimetabolite incorporation (mimicking nucleotides), and RNA-targeted approaches like antisense oligonucleotides (ASOs) or RNA interference (RNAi) to modulate translation (Source: NIH, PubMed).

03

Biological functions

Cell cycleCell proliferationCell deathOther
04

Disease associations

CancerInfectionOther
05

Safety considerations

GenotoxicitySecondary malignanciesMyelosuppressionTeratogenicityOff-target RNA binding
06

Interacting drugs

Cisplatin

7 more in the full profile.

07

Biomarkers

Microsatellite instability (MSI)Tumor mutational burden (TMB)gamma-H2AX (DNA damage marker)Circulating tumor DNA (ctDNA)

Beyond the preview

Go deeper on Cellular Nucleic Acids (DNA and RNA) (DNA/RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular Nucleic Acids (DNA and RNA) (DNA/RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call